Brief: Astrazeneca Pharma India Gets Tax Order With Estimated Tax Impact Of 33 Million Rupees
27/11/2025 14:46
Nov 27 (Reuters) - Astrazeneca Pharma India Ltd ASTR.NS: ASTRAZENECA PHARMA INDIA LTD - GETS TAX ORDER WITH ESTIMATED TAX IMPACT OF 33 MILLION RUPEES Source text: ID:nNSE9gThnL Further company coverage: ASTR.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan
India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop
Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
Brief: Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication